If you would like to inquire about all open trials, please contact 919.684.3401.
1 trial identified.
AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NCS#683864) Added to High Risk Stratum Treatment Phase: Phase III Sponsor: Cooperative Group Initiated Principal Investigator: Susan Kreissman Contact: Dr. Susan Kreissman Phone: 919.684.3401 Purpose: This phase III trial studies the side effects and how well risk-based therapy works in treating younger patients with newly diagnosed liver cancer. Surgery, chemotherapy drugs (cancer fighting medicines), and when necessary, liver transplant, are the main current treatments for hepatoblastoma. The stage of the cancer is one factor used to decide the best treatment. Treating patients according to the risk group they are in may help get rid of the cancer, keep it from coming back, and decrease the side effects of chemotherapy. Reference Number: 00021079 View this trial at ClinicalTrials.gov
Ways To Give
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.